Key result
Ivabradine is linked to a ~41-bpm heart rate reduction in infants with symptomatic heart failure.
Why the study?
Evidence on the use of ivabradine off-label in pediatric patients under 6 months with symptomatic heart failure or supraventricular tachycardia is limited, necessitating further evaluation of its efficacy, safety, and dosing.
Observational (n=13)
No
Answers are grounded in this paper and cite their sources.
Multifocal atrial tachycardia has certain electrocardiographic similarities to atrial fibrillation. The mechanism of atrial fibrillation is heterogenous but in some cases may arise from a single ectopic driver with fibrillatory conduction to the rest of the atria. This has led to the speculation that multifocal atrial tachycardia may have a similar mechanistic unifocal site that disperses through the atrium in a fibrillatory pattern. Ivabradine has been reported to be efficacious in an adult with paroxysmal atrial fibrillation as well as in children with junctional or ectopic atrial tachycardias. This is the first report of successfully using ivabradine, a novel anti-arrhythmic If blocking agent, to convert multifocal atrial tachycardia in a 5-month-old critically ill infant to a pattern indicating a single ectopic atrial focus. This allowed the patient's single atrial focus to be ablated with return to sinus rhythm and decannulation from ventriculoarterial extracorporeal membrane oxygenation. This case suggests that multifocal atrial tachycardia may arise from a single automatic focus with downstream fibrillatory conduction to the atria.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (2020) conducted an observational in Symptomatic heart failure and supraventricular tachycardia (n=13). Ivabradine was evaluated on Reduction in heart rate from baseline (Mean reduction of 40.7 bpm in heart failure patients and 54.7 bpm in SVT patients, p=0.04 (HF); 0.02 (SVT)). Off-label ivabradine therapy significantly reduced heart rate by a mean of 40.7 bpm in infants with symptomatic heart failure and by 54.7 bpm in those with supraventricular tachycardia.
Synapse has enriched 10 related papers. Consider them for comparative context: